Latest news
26.09.2019
2019 Half-year consolidated results: Deinove’s progress coming to fruition
Launch of the Phase II trial testing DNV3837 for first-line treatment of moderate to severe Clostridioides difficile infections...
23.09.2019
Integration of CRISPR-cas9 technology to accelerate the discovery of innovative antibiotics
DEINOVE strengthens its expertise in the genetic engineering of rare and varied microorganisms to accelerate the discovery and optimization...
18.09.2019
The efficacy of Hebelys® once again demonstrated and promoted in the International Journal of Cosmetic Science
New in vitro and clinical efficacy data have been published; Sphingomonas hydrophobicum extract, the active substance of Hebelys®,...
Press Coverage
19.06.2019
DEINOVE among The Top 20 Industrial Biotechnology Companies in Europe
Europe’s industrial biotechnology sector is driving a massive change from petrochemical processes to more sustainable alternatives. Here...
14.06.2019
Formule Verte | Deinove et Avril avancent sur leur nouvelle gamme d’ingrédients
La société de biotechnologies industrielles Deinove et Avril, l’acteur industriel et financier des filières des huiles et des protéines,...
05.06.2019
Zone Bourse | DEINOVE : LCM confirme sa recommandation d'Achat
LCM a confirmé sa recommandation d'Achat et son objectif de cours de 2,7 euros sur Deinove après la signature d'un partenariat avec Dow...